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INTRODUCTION:
Gestational diabetes is the type of diabetes that occurs
in pregnancy. According to WHO criteria, females with
pregnancy beyond first trimester having FBS equals to
or more than 5.5 mmol/l(100mg/dl) and post prandial
glucose levels  greater than 7 mmol/l (126mg/dl)  are
diagnosed as having gestational diabetes mellitus
(GDM).1,2 Pregnancy is a potentially glucose intolerant
condition and in all pregnancies insulin sensitivity
decreases as the pregnancy advances predisposing the
females to develop GDM.3
The prevalence of GDM is on the verge of rising, from
1995 to 2005, it is documented to have increased by 45%
overall, that is from 3.0 to 4.4% worldwide. Women in
South Asia are documented to be at the highest risk to
develop GDM.4, 5 It is seen in approximately 3-9% of
pregnancies
Placenta plays an important role in fetal nutrition and
growth as it is concern with supply of oxygen, nutrients,
immunoglobins and also releases multiple hormones for
the continuation of pregnancy.6 It is a connecting unit
between mother and the fetus thus provides the
information regarding infants prenatal experiences7.
Human placenta has a complex vascular system  that
allows exchange of different materials with fetal and
maternal blood.8 The successful development, growth
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and maturity of feto-placental vessels are important for
 normal fetal growth  and survival.9
As glucose in the blood can cross placenta, the fetus gets
exposed to hyperglycemic blood coming from the diabetic
mother through umbilical cord.  By the end of 12th week
of gestation, fetal pancreas takes over the function of
production and release of insulin10. Insulin is a very
important metabolic hormone.  It is necessary for proper
entry and utilization of glucose in the cell. As large
amount of glucose enter the fetal blood, excessive
production of insulin occurs from fetal pancreas. Thus
large amount of glucose gets stored in the form of
glycogen in the cell, resulting in macrosomic babies and
multiple complications. Hyper-insulinemia in utero affects
fetus as well as placenta. 11
Thus any metabolic change as in Gestational Diabetes
Mellitus in maternal blood can affect placental
morphology  and functioning.12 It is said that early
diagnosis and prompt treatment of GDM females is very
important so as to avoid multiple obstetric complications
and  adverse maternal and fetal outcomes such as cesarean
section due to macrosomic babies, fetal distress,congenital
abnormalities,  respiratory distress syndrome,
hyperbilirubinemia, polycythemia, and at times
unexplained term intrauterine death and still births 13.
This study was carried out to observe thegross morphology
of placentaand feto-maternal outcomein patients having
gestational diabetes mellitus receiving oral and or
parenteral therapy along with diet control and exercise.
MATERIALS AND METHODS:
This descriptive pilot study was carried out in June-July
2010,at Lyari General Hospital and Mamji Hospital,
Karachi following approval by IRB and ERB of
DowUniversity of Health Sciences, Karachi as a part to
fulfill the requirement of M Phil.Verbal informed consent
was taken and after delivery 20 placentae were collected
from the GDM patients who received oral and
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or parenteral treatment with diet control and exercise
during pregnancy.The placentae were preserved in 10%
formalin within 30-40 minutes of delivery.Placental gross
findings were documented on a predesigned data form
including name, age, weight and height of the patient,
weight, size consistency of placental tissue, attachment,
size and color of the cord, membranes complete or
incomplete, retroplacental hemorrhages and any other
gross abnormality in the placental tissue.Fetal and
maternal outcome were observed by determinants as fetal
health and weight and mode of delivery respectively.Data
was evaluated by using SPSS version16.
RESULTS:
Mean patients age was 32.45±4.51years, mean patient
weight was 80.62±5.83grams. Fasting and random blood
sugar level were 115±35.1 mg/dl and 252±65.97 mg/dl
respectively. (Table 1) Mean placental sizewas 18.3±3.22
cm and 14.2±2.14 cm in two dimensions with mean
placental width of 2.4±0.94 cm. Mean placental weight
was 680± 122.9 grams, mean cord length was 19.55±7.22
cm and mean cord width 1.17±0.51cm (Table 2a)Out of
20 placentae, 13 placentae were disc shaped, 19 placentae
were soft in consistency, 8 were blue in color, 7 had
central insertion of umbilical cord, 14 had complete
membranes and 16 had other gross pathologies such as
hemorrhages, fibrinoid necrosis etc.  (Table 2b)Weight
of the baby was 3.4±0.38 kg. There was 1 intrauterine
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Gestational diabetes is any degree of glucose intolerance
that occurs in pregnant females after 1st trimester of
pregnancy.  Gestational diabetes is said to produce changes
in placenta as placental tissues are liable to change with
maternal metabolic issues.
In our results, patients mean age and weight were
32.45±4.51 years and 80.62±5.83kg respectively. Debelle
took the similar gestational diabetics patients for her
study14
Territi K,  Ekbald U, Vehlberg T, Ronnemaa T.
Comparison of metformin and insulin in the treatment
of gestational diabetes :A retrospective ;Case Control
Study.Rev Diabet Stud 2008 ;5(2):95-101.
Serlin DC, Lash RW. Diagnosis and management of
gestational diabetes. Am Fam  Physician 2009
;80(1):57-62.
Catalano PM, Kirvan JP, Mouzon SH,King J.
Gestational diabetes and insulin resistance: Role in
long and short term complications for mother and
fetus. J Nutr 2003;133:1638 -78.
Hassan JA, Karim N, Sheikh Z. Metformin prevents
macrosomia and neonatal morbidity in Gestational
Diabetes.Pak J Med Sci 2012; 28(3):384-89.
Anna V, Von Der Ploeg HP, Cheung NW, Hulxley
R, Bauman AE. Socio-demographic correlates of the
increasing trends in prevalence of Gestational
Diabetes Mellitus in a large population of women
between 1995 and 2005. Diabetic Care 2008;31:
2288-93.
Alonso A, DelRey CG, Navarro A, Tolivia J, Gonzalez
CG .Effects of gestational diabetes mellitus on
proteins implicated in insulin signaling  in human
placenta.GynecolEndocrinol  2006 ;22(9):526-35.
Bernirchke K .The Placenta: How to examine it and
what you can learn. ContempObst and Gynecol
1981;17:117-19.
Leach L, Taylor A, Sciota F. Vascular dysfunction
in the diabetic placenta: cause and consequences. J
Anat 2009 ;215:69-76
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Our results have shown that placental size and weight in
GDM females 18.3×14.2cm and 694gms respectively.
Kucuk had stated the same in his research that placental
weight and size was 18 cm and weight 694 grams in
GDM females and this is coinciding to our results15.
These results also coincide with the work of Ashfaq16
and Akhter17 with similar diabetic placentae weight,
central thickness and diameter and the results of both
these studies are in favor of our findings.
Yalter has documented that in normal pregnancyan
average placental length is 22 cm (9 inch) and width is
2-2.5 cm (0.8-1 inch). It typically weighs approximately
500 grams (1 lb). It has a pale, dark reddish or maroon
color. It is connected to the fetus by an umbilical cord
of approximately 55-60 cm (22-24 inch) in length that
contains two arteries and one vein.18 Placentae in our
study had weight much higher than described by Yalter
indicating that they were not normal.Umbilical cord
length and thickness depends on the amount of whartson
jelly present and the vessels luminal diameter.The results
described by Predanicare in concurrence with our findings
of placental cords length and thickness.19
Verma has discussed about major gross examination of
placentae including membrane completeness, placental
shape, consistency, cord insertion, cord color and gross
pathologies such as fibrinoid necrosis and hemorrhages
and the results are similar to ours 20 Villous fibrinoid
necrosis is an established old coagulative infarcted tissue
with fibrin deposition which probably is derived from
plasma and has leaked out of necrotic villi. Villous
necrosis was present in 16(80%) GDM placentae. It has
been noticed that massive fibrin deposition can lead to
fetal growth restriction and fetal death21,22. Tewari stated
the similar figures (80%) regarding fibrinoid necrosis in
diabetic placentae23
Fetal hyper-insulinemia had direct and indirect effects
on placental tissue probably producing excessive growth
and increase in placental weight. Increased placental
volume compensates the need of growing babies to an
extent and after that state of hypoxia generates leading
to adverse fetal and maternal outcomes, even at times
unexplained termed intrauterine deaths.24
When fetal outcomes were compared, it was seen that
babies were good weight i.e3.43kgs which is similar to
the fetal outcomes documented by Odar. The normal
reference rang for a term baby at 97th percentile is
3.23kgs 25. This shows that babies of our GDM females
were heavier than documented facts.  The reason behind
thismight be the hyper-insulinemic state of the fetus
affecting both the placental and fetal growth26. Jansson
described that probably excessive fetal growth is the
result of increase in substrate availability which stimulates
fetal insulin secretion and its growth. Finally in diabetic
pregnancies, the defect lies in altered placental nutrient
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transport and metabolism.27
In our study, cesarean section rate was high (65%).
Goldman has stated the same with probable reason of
increased fetal weight in GDM group.28
There was 1 intrauterine death out of 20 fetuses that is
5%.Excessive growth of fetus which increases the oxygen
demands could be responsible for this outcome. It has
been documented that placenta tries to compensate this
to an extent but when the baby is grown enough and is
near term, it cannot fulfill the requirements of fetus
resulting in unexplained term intrauterine death in these
patients.Gaunter has stated the same and his results are
coinciding with our findings 29, 30
CONCLUSION:
Gross morphology of placenta exhibited multiple
deformities with adverse fetal and maternal outcomes.
Future studies regarding placental and feto-maternal
outcome should be undertaken to evaluate and compare
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